Chugai Pharmaceutical Signs Licensing Deal with Rani Therapeutics for Oral Drug Development

The agreement enables Chugai to use Rani Therapeutics’ platform for developing and commercializing innovative oral formulations.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Licensing Agreement: A formal contract granting one party rights to use another’s intellectual property or technology for commercial purposes.
  • Oral Formulations: Pharmaceutical preparations designed to be administered through the mouth, enabling easier dosing and improved patient compliance.